NCT02157714View on ClinicalTrials.gov

Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2016

Conditions
Parkinson's Disease
Interventions
DRUG

PRX002

OTHER

Placebo

Trial Locations (8)

32806

Compass Research, LLC, Orlando

33009

MD Clinical, Hallandale

33486

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

48025

QUEST Research Institute, Bingham Farms

77030

Baylor College of Medicine, Houston

90806

Collaborative Neuroscience Network, LLC, Long Beach

97239

Oregon Health and Science University, Department of Neurology, Portland

06510

Institute for Neurodegenerative Disorders, New Haven

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Prothena Biosciences Limited

INDUSTRY

NCT02157714 - Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter